Literature DB >> 25525158

Transition to Adult Mental Health Services for Young People With ADHD.

Laura Reale1, Maria Antonella Costantino2, Marco Sequi1, Maurizio Bonati1.   

Abstract

OBJECTIVE: To investigate the care management and continuity from child to adult mental health service for young adults with ADHD.
METHOD: A questionnaire survey from 18 Regional ADHD Pediatric Centers (RAPC) in Lombardy, Italy, was used to collect data on transition protocols and population served, and to track the pathway of care of ADHD patients once they reached adulthood.
RESULTS: Twenty-eight percent of RAPC had transition protocols and 3% of the population annually served were potential referrals to adult service. Of 52 patients who turned 18 years, just over 70% were monitored by the general practitioner, of those 5 with RAPC support. One fifth of patients continued to use mental health services, the majority was still monitored by the RAPC, and only three by services for adult.
CONCLUSION: Managing the process of transition to adult services in mental health care remains a need to be prioritized and better defined for ADHD patients.

Entities:  

Keywords:  ADHD; adult ADHD; health service use

Mesh:

Year:  2014        PMID: 25525158     DOI: 10.1177/1087054714560823

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  2 in total

Review 1.  Identifying core components and indicators of successful transitions from child to adult mental health services: a scoping review.

Authors:  Kristin Cleverley; Emily Rowland; Kathryn Bennett; Lianne Jeffs; Dana Gore
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-08       Impact factor: 4.785

2.  Comparison of Emotional Dysregulation Features in Cyclothymia and Adult ADHD.

Authors:  Giulio Emilio Brancati; Margherita Barbuti; Elisa Schiavi; Paola Colombini; Martina Moriconi; Alessandro Pallucchini; Marco Maiello; Giulia Menculini; Giulio Perugi
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.